SCHEMBL3940317

SCHEMBL3940317

COc1ccc2[nH]c(B(O)O)c(C(=O)OC(C)(C)C)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
KDM4E B2RXH2 6/20 0.45
HSD17B10 Q99714 5/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TSHR P16473 2/20 0.45
GFER P55789 1/20 0.45
HPGD P15428 5/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MTNR1A P48039 2/20 0.42
MTNR1B P49286 2/20 0.42
AKR1C2 P52895 1/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3940036 0.90 KDM4E (0.45) ALDH1A1KDM4EHSD17B10MAPTMEN1
SCHEMBL31196064 0.84 GABRA1 (0.55) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL4069744 0.84 GABRA1 (0.55) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL3949097 0.82 GABRA1 (0.48) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL3649418 0.81 GABRA1 (0.50) MEN1KMT2AL3MBTL1GABRA1GABRG2
SCHEMBL3788709 0.80 GABRA1 (0.49) ALDH1A1KDM4EHSD17B10MAPTMEN1
SCHEMBL6643564 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10MAPTMEN1
SCHEMBL4842628 0.78 KIF11 (0.45) KDM4EKMT2AGAAGABRA1GABRG2
SCHEMBL5960262 0.77 RAB9A (0.52) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL14174312 0.74 KDM4E (0.60) ALDH1A1KDM4EHSD17B10MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3193902-A1 mTORC1 INHIBITORS The Regents of The University of California (US) 2017-07-26 EP disclosed
WO-2016040806-A1 mTORC1 INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-03-17 WO disclosed
EP-2121655-A1 NOVEL 2-HETEROARYL SUBSTITUTED INDOLES 695 AstraZeneca AB (SE) 2009-11-25 EP disclosed
EP-2049536-A2 POLYCYCLIC VIRAL INHIBITORS GENELABS TECHNOLOGIES, INC. (US) 2009-04-22 EP disclosed
EP-2044051-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB (publ) (SE) 2009-04-08 EP disclosed
WO-2008108729-A1 NOVEL 2-HETEROARYL SUBSTITUTED INDOLES 695 ASTRAZENECA AB (SE) 2008-09-12 WO disclosed
WO-2008011521-A2 POLYCYCLIC VIRAL INHIBITORS GENELABS TECHNOLOGIES, INC. (US) 2008-01-24 WO disclosed
WO-2007147874-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB (PUBL) (SE) 2007-12-27 WO disclosed
WO-2007047646-A2 SUBSTITUTED DIHYDRO-ISOINDOLONES USEFUL IN TREATING KINASE DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-04-26 WO disclosed